These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23831824)

  • 1. Cancer vaccines in the immunotherapy era: rational approach.
    Kim DS
    Hum Vaccin Immunother; 2013 Sep; 9(9):2017-8. PubMed ID: 23831824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant cancer vaccines and new vaccine targets. Interview by Jenaid Rees.
    Schlom J
    Expert Rev Vaccines; 2013 Oct; 12(10):1121-4. PubMed ID: 24098990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.
    Fecek RJ; Storkus WJ
    Immunotherapy; 2016 Oct; 8(10):1205-18. PubMed ID: 27605069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial.
    Baek S; Kim CS; Kim SB; Kim YM; Kwon SW; Kim Y; Kim H; Lee H
    J Transl Med; 2011 Oct; 9():178. PubMed ID: 22013914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New directions in immunotherapy for malignant solid tumors].
    Okuno K; Sugiura F; Sukegawa Y; Inoue K
    Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol.
    Qomlaqi M; Bahrami F; Ajami M; Hajati J
    Math Biosci; 2017 Oct; 292():1-9. PubMed ID: 28713023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems vaccinology for cancer vaccine development.
    Petrizzo A; Tagliamonte M; Tornesello M; Buonaguro FM; Buonaguro L
    Expert Rev Vaccines; 2014 Jun; 13(6):711-9. PubMed ID: 24766452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: Cancer Immunology Special Issue-Immunotherapy.
    Kawakami Y
    Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune based therapies in cancer.
    Krüger C; Greten TF; Korangy F
    Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the cancer vaccine field: are we moving forward?
    Kudrin A; Hanna MG
    Hum Vaccin Immunother; 2012 Aug; 8(8):1135-40. PubMed ID: 22854670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic cancer vaccines: a long and winding road to success.
    Baxevanis CN; Papamichail M; Perez SA
    Expert Rev Vaccines; 2014 Jan; 13(1):131-44. PubMed ID: 24224539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
    Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.
    Wang HY; Wang RF
    Adv Immunol; 2012; 114():151-76. PubMed ID: 22449781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of more effective cancer vaccines.
    Fenoglio D; Traverso P; Parodi A; Kalli F; Zanetti M; Filaci G
    Hum Vaccin Immunother; 2013 Dec; 9(12):2543-7. PubMed ID: 23978951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer vaccines in the new era of cancer immunotherapy.
    Knutson KL; Mittendorf EA
    Vaccine; 2015 Dec; 33(51):7376. PubMed ID: 26432907
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy of solid tumor: perspectives on vaccine and cell therapy].
    Ikeda H; Shiku H
    Nihon Rinsho; 2012 Dec; 70(12):2043-50. PubMed ID: 23259373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations.
    Gatti-Mays ME; Redman JM; Collins JM; Bilusic M
    Hum Vaccin Immunother; 2017 Nov; 13(11):2561-2574. PubMed ID: 28857666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation approaches for tumor vaccination.
    Patel A; Kaufman HL; Disis ML
    Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.